Patents by Inventor Sutisak Kitareewan

Sutisak Kitareewan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG215 and/or UBP43
    Patent number: 8697668
    Abstract: Compositions and methods of using compositions that induce UBE1L or a ubiquitin-like protein ISG15, or inhibit a deconjugase UBP43 to degrade oncogenic proteins and enhance apoptosis of cancer (neoplastic) or pre-cancerous (pre-neoplastic) cells are provided. Methods for the prevention or treatment of cancer via administration of these compositions are also provided.
    Type: Grant
    Filed: September 17, 2012
    Date of Patent: April 15, 2014
    Assignee: Trustees of Dartmouth College
    Inventors: Ethan Dmitrovsky, Bret C. Hassel, Sutisak Kitareewan, Ian Pitha-Rowe
  • Compositions and Methods for Preventing and Treating Cancer via Modulating UBE1L, ISG215 and/or UBP43
    Publication number: 20130041016
    Abstract: Compositions and methods of using compositions that induce UBE1L or a ubiquitin-like protein ISG15, or inhibit a deconjugase UBP43 to degrade oncogenic proteins and enhance apoptosis of cancer (neoplastic) or pre-cancerous (pre-neoplastic) cells are provided. Methods for the prevention or treatment of cancer via administration of these compositions are also provided.
    Type: Application
    Filed: September 17, 2012
    Publication date: February 14, 2013
    Applicant: Trustees of Dartmouth College
    Inventors: Ethan Dmitrovsky, Bret C. Hassel, Sutisak Kitareewan, Ian Pitha-Rowe
  • Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG15 and/or UBP43
    Patent number: 8283113
    Abstract: Compositions and methods of using compositions that induce UBE1L or a ubiquitin-like protein ISG15, or inhibit a deconjugase UBP43 to degrade oncogenic proteins and enhance apoptosis of cancer (neoplastic) or pre-cancerous (pre-neoplastic) cells are provided. Methods for the prevention or treatment of cancer via administration of these compositions are also provided.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: October 9, 2012
    Assignee: Trustees of Dartmouth College
    Inventors: Ethan Dmitrovsky, Bret A. Hassel, Sutisak Kitareewan, Ian Pitha-Rowe
  • Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation
    Patent number: 8124371
    Abstract: The present invention relates to compositions for destabilizing lysosomes to increase the degradation of oncogenic or aberrant proteins for the prevention or treatment of disease. Methods for identifying agents which destabilize lysosomes are also provided as are agents identified in accordance with the screening method.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: February 28, 2012
    Assignee: Trustees of Dartmouth College
    Inventors: Sutisak Kitareewan, Roger Sloboda, Ethan Dmitrovsky
  • Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG15 and/or UBP43
    Publication number: 20090131357
    Abstract: Compositions and methods of using compositions that induce UBE1L or a ubiquitin-like protein ISG15, or inhibit a deconjugase UBP43 to degrade oncogenic proteins and enhance apoptosis of cancer (neoplastic) or pre-cancerous (pre-neoplastic) cells are provided. Methods for the prevention or treatment of cancer via administration of these compositions are also provided.
    Type: Application
    Filed: October 31, 2008
    Publication date: May 21, 2009
    Inventors: Ethan Dmitrovsky, Bret A. Hassel, Sutisak Kitareewan, Ian Pitha-Rowe
  • Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation
    Publication number: 20060228425
    Abstract: The present invention relates to compositions and methods for destabilizing lysosomes to increase the degradation of oncogenic or aberrant proteins for the prevention and treatment of disease. Methods for identifying agents which destabilize lysosomes are also provided as are agents identified in accordance with the screening method.
    Type: Application
    Filed: July 30, 2004
    Publication date: October 12, 2006
    Inventors: Sutisak Kitareewan, Roger Sloboda, Ethan Dmitrovsky
  • Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43
    Publication number: 20050148502
    Abstract: Compositions and methods of using compositions that induce UBE1L or a ubiquitin-like protein ISG15 or inhibit a deconjugase UBP43 to degrade oncogenic proteins and enhance apoptosis of cancer (neoplastic) or pre-cancerous (pre-neoplastic) cells are provided. Methods for the prevention or treatment of cancer via administration of these compositions are also provided.
    Type: Application
    Filed: March 5, 2003
    Publication date: July 7, 2005
    Inventors: Ethan Dmitrovsky, Bret Hassel, Sutisak Kitareewan, Ian Pitha-Rowe